HUMAN STUDY COMT and DRD3 haplotype-associated pain intensity and acute care utilization in adult sickle cell disease
- 12 March 2022
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 247 (17) , 1601-1608
Abstract
A previous exploratory analysis of a COMT gene single-nucleotide polymorphism (SNP) and a DRD3 SNP by our group suggested possible contributions to pain-related acute care utilization in people with sickle cell disease (SCD). Our aim was to extend the analysis to gene-spanning haplotypes of COMT SNPs and DRD3 SNPs to investigate possible associations with pain intensity and pain-related acute care utilization in an SCD cohort. Genotyping was conducted, and clinical data were collected, including self-reported pain intensity using PAINReportIt® (average of current pain and least and worst in past 24 hours, average pain intensity [API]) and medical record-extracted, pain-related acute care utilization data of 130 adults with SCD. Haplotype blocks were identified based on linkage disequilibria (COMT = 7 haploblocks; DRD3 = 8 haploblocks). Regression analyses were tested for association between haplotypes and API and utilization, yielding several significant findings. For COMT block 1 (rs2075507, rs4646310, rs737865), the A-G-G haplotype was associated with higher API compared to the reference A-G-A ( p = 0.02), whereas the A-A-A haplotype was associated with higher utilization ( p = 0.02). For DRD3 block 2 (rs9817063, rs2134655, rs963468, and rs3773679), relative to reference T-C-G-C, the T-T-G-C haplotype was associated with higher utilization ( p = 0.01). For DRD3 block 4 (rs167770, rs324029, and rs324023), the A-G-T haplotype was associated with higher API ( p = 0.04) and utilization ( p < 0.001) relative to reference G-A-T, whereas the A-A-T haplotype was associated with higher utilization ( p = 0.01). We found COMT and DRD3 haplotypes associated with pain-related SCD features, suggesting that in future studies more emphasis be placed on cis effects of SNP alleles in evaluating genetic contributions to SCD pain and acute care utilization for pain.Keywords
Funding Information
- National Institute on Aging (T32AG049673)
- National Heart, Lung, and Blood Institute (1R01 HL078536)
- National Heart, Lung, and Blood Institute (K01HL153210-01)
This publication has 44 references indexed in Scilit:
- Complex Multilocus Effects of Catechol-O-Methyltransferase Haplotypes Predict Pain and Pain Interference 6 Weeks After Motor Vehicle CollisionNeuroMolecular Medicine, 2013
- Pain modality- and sex-specific effects of COMT genetic functional variantsPain, 2013
- Can Heterogeneity of Chronic Sickle-Cell Disease Pain Be Explained by Genomics? A Literature ReviewBiological Research For Nursing, 2009
- Sex, Gender, and Pain: A Review of Recent Clinical and Experimental FindingsThe Journal of Pain, 2009
- Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT genePain, 2007
- A functional variant of the dopamine D 3 receptor is associated with risk and age-at-onset of essential tremorProceedings of the National Academy of Sciences, 2006
- The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patientsPain, 2005
- Optimizing DNA yield from buccal swabs in the elderly: Attempts to promote buccal cell growth in cultureAmerican Journal of Human Biology, 2003
- Score Tests for Association between Traits and Haplotypes when Linkage Phase Is AmbiguousThe American Journal of Human Genetics, 2002
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990